The serotonergic system may be involved in the sleep-inducing action of oleamide in rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 6, 2003, Pages 457-462

  Yang, Jing Yu ^a   Wu, Chun Fu ^a   Wang, Fang ^a   Song, Hong Rui ^a   Pan, Wen Jun ^a   Wang, Yu Ling ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

8 OH DPAT; Fenfluramine; Fluoxetine; Oleamide; Sleep; WAY 100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BUSPIRONE; FENFLURAMINE; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OLEAMIDE; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; ELECTROENCEPHALOGRAM; ELECTROMYOGRAPHY; MALE; NONHUMAN; RAT; REM SLEEP; SEROTONINERGIC SYSTEM; SLEEP; SLEEP INDUCTION; SLOW WAVE SLEEP; WAKEFULNESS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BUSPIRONE; FENFLURAMINE; FLUOXETINE; HYPNOTICS AND SEDATIVES; MALE; NEURAL PATHWAYS; OLEIC ACIDS; PIPERAZINES; PYRIDINES; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SLEEP; SLEEP, REM; WAKEFULNESS;

EID: 0347991795     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0843-z     Document Type: Article

References (38)

1. Basile AS, Hanus L, Mendelson WB (1999) Characterization of the hypnotic properties of oleamide. Neuroreport 10:947-951
2. Boger DL, Henriksen SJ, Cravatt BF (1998a) Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. Curr Pharm Des 4: 303-314
3. 1A serotonin receptor potentiation by the biological active lipid oleamide. Proc Natl Acad Sci USA 95:4102-4107
4. Cape EG, Jones BE (1998) Differential modulation of high frequency gamma electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons. J Neurosci 18:2653-2666
5. 2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptor. Neurophamarcology 38:533-541
6. Coyne L, Lees G, Nicholson RA, Zheng J, Neufield KD (2002) The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro. Br J Pharmacol 135:1977-1987
7. Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL, Lerner RA (1995) Chemical characterization of a family of brain lipids that induce sleep. Science 268:1506-1509
8. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83-87
9. De Montigny C, Blier P (1984) Effects of antidepressant treatments on 5-HT neurotransmission: electrophysiological and clinical studies. Adv Biochem Psychopharmacol 39:223-239
10. Fedorova I, Hashimoto A, Fecik RA, Hedrick MP, Hanus LO, Boger DL, Rice KC, Basile AS (2001) Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J Pharmacol Exp Ther 299:332-342
11. Fornal C, Radulovacki M (1983a) Sleep suppressant action of fenfluramine in rats: Relation to postsynaptic serotonergic stimulation. J Pharmacol Exp Ther 225:667-674
12. Fornal C, Radulovacki M (1983b) Sleep suppressant action of fenfluramine in rats: evidence against the involvement of presynaptic serotonergic mechanism. J Pharmacol Exp Ther 225:675-681
13. Gao B, Duncan WC Jr, Wehr TA (1992) Fluoxetine decreases brain temperature and REM sleep in Syrian hamsters. Psychopharmacology 106:321-329
14. Hedlund PB, Carson MJ, Sutcliffe JG, Thomas EAI (1999) Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors. Biochem Pharmacol 58:1807-1813
15. Huidobro-Toro JP, Harris RA (1996) Brain lipids that induce sleep are novel modulators of 5-HT receptors. Proc Natl Acad Sci USA 93:8078-8082
16. Huitron-Resendiz S, Gombart L, Cravatt BF, Henriksen SJ (2001) Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats. Exp Neurol 172:235-243
17. Hyttel J (1994) Pharmacological characterization of the selective serotonin reuptake inhibitors (SSRI's). Int Clin Psychopharmacol 9:19-26
18. Laposky AD, Homanics GE, Basile A, Mendelson WB (2001) Deletion of the GABA(A) receptor beta 3 subunit eliminates the hypnotic actions of oleamide in mice. Neuroreport 12:4143-4147
19. A receptors and inhibitory synaptic currents by the endogenous CNS sleep regulator cis-9,10-octadecenoamide (cOA). Br J Pharmacol 124:873-882
20. Lerman JA, Kaitin KI, Dement WC, Peroutka SJ (1986) The effects of buspirone on sleep in the rat. Neurosci Lett 72:64-68
21. Mechoulam R, Fride E, Hanus L, Sheskin T, Bisogno T, Di Marzo V, Bayewitch M, Vogel Z (1997) Anandamide may mediate sleep induction. Nature 389:25-26
22. Mendelson WB, Basile AS (1999) The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. Neuroreport 10:3237-3239
23. Mendelson WB, Basile AS (2000) Synergistic interaction of the hypnotic effects of oleamide and triazolam (abstract). Sleep 23 (Suppl. 2):A162
24. Mistlberger RE, Bergamnn BM, Waldenar W, Rechtschaffen A (1983) Recovery sleep following sleep deprivation in intact and suprachiastmatic nuclei-lesioned rats. Sleep 6:217-233
25. 1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat. J Sleep Res 1:169-175
26. Monti JM, Jantos H (1994) Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness Neuropharmacology 33:705-708
27. Monti JM, Jantos H, Silveira R, Reyes-Parada M, Scorza C (1995) Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone. Pharmacol Biochem Behav 52:305-312
28. Nicholson AN, Pascoe PA (1988) Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor. Neuropharmacology 27:597-602
29. Obal F Jr, Tobler I, Borbley AA (1983) Effect of ambient temperature on 24 h sleep-wake cycle in normal and caspsaician treated rats. Physiol Behav 30:425-430
30. Pastel RH, Fernstrom JD (1987) Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on EEG in the rat. Brain Res 436:92-102
31. Portas CM, Bjorvatn B, Ursin R (2000) Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies. Prog Neurobiol 60:13-35
32. Sakai K, Crochet S (2001) Differentiation of presumed serotonergic dorsal raphe neurons in relation to behavior and wake-sleep states. Neuroscience 104:1141-1155
33. 1A receptor antagonist p-MPPI antagonizes sleep-waking and behavioral effects of 8-OH-DPAT in rats. Behav Brain Res 121:181-187
34. Thomas EA, Carson MJ, Neal MJ, Sutcliffe JG (1997) Unique allosteric regulation of 5-HT receptor-mediated signal transduction by oleamide. Proc Natl Acad Sci USA 94:14115-14119
35. Thomas EA, Carson MJ, Sutcliffe JG (1998) Oleamide-induced modulation of 5-hydroxytryptamine receptor-mediated signaling. Ann NY Acad Sci 861:183-189
36. Thomas TC, Kumar VM (2000) Effect of ambient temperature on sleep-wakefulness in normal and medial preoptic are lesioned rats. Sleep Res Online 3:141-145
37. + channels in vitro: a putative endogenous ligand for depressant drug site in CNS. Br J Pharmacol 129:283-290
38. Yang JY, Wu CF, Song HR (1999) Studies on the sedative and hypnotic effects of oleamide in mice. Arzneim-Forsch/Drug Res 49:663-667